ArticleMaterials today. Bio2026
4D fabrication of scaffolds facilitates the construction of cholangiocyte monolayers from human and mouse liver derived organoids.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Smart Bioinks for 4D Bioprinting: Requirements, Design, and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The blockage and absence of bile ducts lead to liver defects, highlighting the urgent need for effective regenerative solutions. Tissue engineering has emerged as an interdisciplinary solution for repairing and regenerating damaged bile duct tissue. However, challenges such as achieving good organoid viability and morphological remodeling within scaffolds remain. In this study, surface-modified biodegradable shape memory (SMP) scaffolds were designed and fabricated to construct cell-laden 3D bile duct tubes using both human and mouse liver derived cholangiocyte organoids as cell sources. The SMP scaffolds demonstrate superb biocompatibility and good shape memory properties, which support organoid attachment and integration, enhancing cholangiocytes proliferation and monolayer formation. Our cell-laden SMP scaffolds facilitated the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.